 |
(R)-3-[3-Fluoro-4-(1-methyl-1,4,5,6-tetrahydro-1,2,4-triazin-4-yl)phenyl]-5(R)-(hydroxymethyl)oxazolidin-2-one |
|---|---|
| Trade Name | |
| Orphan Indication | Tuberculosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-19 00:00:00 |
| Sponsor | LegoChem Biosciences, Inc.;8-26 Munpyeongseo-ro;Daejeon |
